Evidence map›Paper›PMID 32526838›Full record

ArticleMolecules (Basel, Switzerland)2020

Preparation, Characterization, and Radiolabeling of [

Zarif Ashhar, Nor Azah Yusof, Fathinul Fikri Ahmad Saad, Siti Mariam Mohd Nor, Faruq Mohammad, Wan Hamirul Bahrin Wan Kamal, Muhammad Hishar Hassan, Hazlina Ahmad Hassali, Hamad A Al-Lohedan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. EJNMMI radiopharmacy and chemistry · 2025
    Article
  4. Review
  5. Review
  6. Preparation, Optimisation, and In Vitro Evaluation of [Molecules (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Zarif AshharChemistry Department, Faculty of Science, Putra Malaysia University, Selangor, Serdang 43400, Malaysia.ORCID 0000-0001-5057-4705
Nor Azah YusofChemistry Department, Faculty of Science, Putra Malaysia University, Selangor, Serdang 43400, Malaysia.
Fathinul Fikri Ahmad SaadCentre for Diagnostic Nuclear Imaging (CDNI), Faculty of Medicine and Health Sciences, Putra Malaysia University, Selangor, Serdang 43400, Malaysia.
Siti Mariam Mohd NorChemistry Department, Faculty of Science, Putra Malaysia University, Selangor, Serdang 43400, Malaysia.
Faruq MohammadSurfactants Research Chair, Chemistry, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-9318-9986
Wan Hamirul Bahrin Wan KamalBahagian Teknologi Perubatan, Malaysia Nuclear Agency, Selangor, Kajang 43600, Malaysia.
Muhammad Hishar HassanCentre for Diagnostic Nuclear Imaging (CDNI), Faculty of Medicine and Health Sciences, Putra Malaysia University, Selangor, Serdang 43400, Malaysia.
Hazlina Ahmad HassaliBahagian Teknologi Perubatan, Malaysia Nuclear Agency, Selangor, Kajang 43600, Malaysia.
Hamad A Al-LohedanSurfactants Research Chair, Chemistry, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Universiti Putra Malaysia · MYKing Saud University · SAMalaysian Nuclear Agency · MY

Funding

King Saud University Deanship of Scientific ResearchUniversiti Putra Malaysia UPM/800/2/2/4
6 · The paper itself

Abstract

Early diagnosis of bone metastases is crucial to prevent skeletal-related events, and for that, the non-invasive techniques to diagnose bone metastases that make use of image-guided radiopharmaceuticals are being employed as an alternative to traditional biopsies. Hence, in the present work, we tested the efficacy of a gallium-68 (

Indexed as

AcetatesAnimalsBone and BonesChromatography, High Pressure LiquidGallium RadioisotopesHeterocyclic Compounds, 1-RingMaleMass SpectrometryPamidronatePositron-Emission TomographyRadiopharmaceuticalsRatsRats, Sprague-DawleyTissue Distribution1-(1,3-carboxypropyl)-4,7-carboxymethyl-1,4,7-triazacyclononaneAcetatesGallium-68Gallium RadioisotopesHeterocyclic Compounds, 1-RingPamidronateRadiopharmaceuticals[68Ga]Ga-NODAGA-pamidronic acidbisphosphonatebone metastasesion suppressionpositron emitting tomography (PET), contrasting agentsradiopharmaceuticals

Identifiers

PMID32526838
PMCPMC7321328
OpenAlexW3033502354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.